Molecule.one
PrivateLast Round
Grant
Jun 12, 2025
Total Funding Raised
$5.85M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Molecule.one operates in Healthcare & Life Sciences and is based in Warsaw. Its latest recorded funding round was a Grant round in June 2025.
Molecule.one is a deep-tech chemistry company that develops AI-powered platforms for chemical synthesis and autonomous discovery in the pharmaceutical and biotechnology sectors.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Vertical SaaS
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Molecule.one Comparables
Compare Molecule.one with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Chemical.AI | 89% | |
| PostEra | 88% | |
| Iktos | 86% |
For institutional investors. Book with your work email.
Molecule.one Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 12, 2025 | ||||
| Seed | Jun 4, 2021 | ||||
| Pre Seed | Aug 19, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Molecule.one Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cherubic Ventures | Seed |
| Firlej Kastory | Seed |
| Outsized Ventures | Seed |
| Atmos Ventures | Seed |
| Expeditions Fund | Seed |
| Sunfish Partners | Seed, Pre Seed |
| InVentures | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors grew 94% MoM, reaching 12.1K.
- Jun 24, 2026
Developing the Maria platform, uniting AI, automated lab, and proprietary data.
For institutional investors. Book with your work email.
Molecule.one Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Molecule.one's valuation, stock price, and market status.
Is Molecule.one a public or private company?
Molecule.one is a private company.
What is the current stock price of Molecule.one?
Molecule.one is a private company, so its shares have no public market price. Caplight tracks Molecule.one's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Molecule.one worth (valuation)?
Valuation information for Molecule.one is not publicly available.
Can I buy Molecule.one stock?
Molecule.one shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Molecule.one's last funding round?
Molecule.one's most recent funding round was Grant on June 12, 2025.
Who are the main investors in Molecule.one?
Key investors in Molecule.one include Atmos Ventures, Sunfish Partners.
Will Molecule.one IPO soon?
No public IPO plans have been announced for Molecule.one.
How can I track Molecule.one secondary market activity?
Caplight tracks bids, offers, and trades in Molecule.one's shares on secondary markets.